周五开播 | 从JPM大会,看新的一年行业走向( 二 )


周五开播 | 从JPM大会,看新的一年行业走向
文章图片
肖亮博士
LiangXiao,Ph.D
宜联生物
MediLinkTherapeutics
联合创始人
Co-founder
Dr.LiangXiao,cofounderofMediLinkTherapeutics(Suzhou)andhasservedasthecompany'schiefoperatingofficersinceMarch2021.Heismainlyresponsibleforantibodydiscovery,ADCevaluationandscreening,CMCandpreclinicalevaluation.
Dr.Xiaohas16yearsofexperienceinbiopharmaceuticalresearchinacademiaandindustry.Hehasbeenresponsibleforthediscovery,CMCandpreclinicalresearchofmultipleinnovativeantibodydrugs(includingmAbs,BsAbsandADCs).Amongthem,themostadvancedprogramhasfileBLAinChina,2ADCprogramsareunderPhIIIclinicaltrialsand2ADCprogramsareinPhIclinicaltrialsnow.Notably,multipleADCprogramshavereachedgloballicenseagreementwithMNC.
Dr.Xiaoreceivedhisbachelor'sdegreeinlifesciencefromtheUniversityofScienceandTechnologyofChinain2007andhisdoctor'sdegreeinchemicalengineeringfromtheUniversityofSouthernCaliforniain2013.
周五开播 | 从JPM大会,看新的一年行业走向
文章图片
吴晓东博士
EricWu,Ph.D,MBA
鑫康合生物医药
KanovaBiopharma
商务运营副总裁
VicePresidentofBussinessDevelopment&Operations
17yearsofmedicalresearchandbusinessdevelopmentexperience.
DeepknowledgeofbothUSandChinahealthcareindustries.
DirectorofbusinessdevelopmentatReistoneBiopharma.
InternationalbusinessdevelopmentmanageratQilu-Pharma.
Ph.D.fromTexasA&MUniversity.
M.B.AfromNewYorkUniversity.
周五开播 | 从JPM大会,看新的一年行业走向
文章图片
陳知瑋博士
KennethChen,Ph.D,MBA
柏思荟
bioSeedin
全球商务拓展经理
GlobalBDManager
Morethan12yearsofoverseadrugresearchanddiscoveryexperienceforautoimmunedisease.PreviouslyworkedasdrugdevelopmentresearchteamleaderattheNümbergHospitalimmunologyresearchcenter,Germany.ProjectmanagerinCRO.FunderofBioxix.BDandscientificconsultantforBioPharmadigitalmarketplacestartup.
Combinemultiplesmallmolecularandantibodydrugdevelopmentexperiencesfordifferenttypesofcancerandautoimmunedisease.Pre-INDprojectmanagementforMNCintheCRO.FundingBioxixtoprovidedrugdevelopmentanalysistechnologyandbigdataanalysisplatform.BioPharmamarketplacebusinessmodelconstruction,businessdevelopmentforMNCclients,andfurtherserviceplatformsetupandpenetration.Markingagoodcombinationofdrugdiscoveryexpertisetogetherwithbusinessdevelopmentexperience.
周五开播 | 从JPM大会,看新的一年行业走向
文章图片
张艺林
PeterZhang,MBA,CFA
垦拓资本
CondenseCapital
投资总监
InvestmentDirector
Yearsofmedicalindustryexperiences,deepexpertiseinmedicalequipment,disposables,drugsandIVDmarketingandbusinessdevelopment.HaveservedsuccessivelyinAutobio,Novartis,B.BraunandFreseniusKabi.返回搜狐 , 查看更多
周五开播 | 从JPM大会,看新的一年行业走向】责任编辑: